David Zekan, MD (@zekan_david) 's Twitter Profile
David Zekan, MD

@zekan_david

PGY4 - WVU Department of Urology, aspiring urologic oncologist, all views most certainly my own

ID: 1162702326026706944

calendar_today17-08-2019 12:26:58

16 Tweet

86 Followers

188 Following

Dr_KevinZorn (@dr_kevinzorn) 's Twitter Profile Photo

William Jaffe Jonathan Pavlinec, MD Dr. Steven Kaplan 𝙳𝚊𝚟𝚒𝚍 𝙲𝚊𝚗𝚎𝚜 Matthew Sterling MD Christian Gratzke Bilal Chughtai Dr. Rahul Mehan Thomas RW Herrmann @NaeemBhojani7 Ricardo R Gonzalez MD Amer. Urol. Assn. I just think it’s time we stop treating BPH like a chronic disease (like asthma or psoriasis). We have office based procedure SOLUTIONS to end perpetual meds & yearly bph visits. Evaluate, diagnose and CURE rather than the 1980s approach of Pharma & wait until AE to offer SX

Boston Scientific Urology (@bsc_urology) 's Twitter Profile Photo

Dr. Chad Morley & the WVU Urology team are among the first in the U.S. to complete a LithoVue™ Elite case! LithoVue Elite is designed to help physicians access, visualize & treat kidney stones and make informed, real-time OR decisions. bit.ly/3o7h2Bd

Dr. Chad Morley &amp; the <a href="/WVU_Urology/">WVU Urology</a> team are among the first in the U.S. to complete a LithoVue™ Elite case! LithoVue Elite is designed to help physicians access, visualize &amp; treat kidney stones and make informed, real-time OR decisions. bit.ly/3o7h2Bd
Minhaj Siddiqui (@mmsiddiquimd) 's Twitter Profile Photo

Love being in a specialty with strong residents! Urology new PGY1 residents demonstrated best overall performance of all medical specialties in the AAMC Readiness Survey aamc.org/data-reports/s… Amer. Urol. Assn. Urology Match

Love being in a specialty with strong residents!  Urology new PGY1 residents demonstrated best overall performance of all medical specialties in the <a href="/AAMCtoday/">AAMC</a> Readiness Survey aamc.org/data-reports/s…  <a href="/AmerUrological/">Amer. Urol. Assn.</a> <a href="/UrologyMatch/">Urology Match</a>
Jay Sandlow, MD (@jayman0827) 's Twitter Profile Photo

Congratulations to our newest ⁦MCW Urology⁩ Andrology fellow for 2024-25 ⁦Zachary Werner⁩ Looking forward to a great year. And congrats to all of the other Andrology applicants. #MensHealth ⁦Society for the Study of Male Reproduction

Congratulations to our newest ⁦<a href="/MCWUrology/">MCW Urology</a>⁩ Andrology fellow for 2024-25 ⁦<a href="/ZacharyWerner17/">Zachary Werner</a>⁩   Looking forward to a great year. And congrats to all of the other Andrology applicants. #MensHealth ⁦<a href="/SSMR_malefactor/">Society for the Study of Male Reproduction</a>⁩
Joon Kyung Kim, MD 김준경 (@joonkyung_kim) 's Twitter Profile Photo

Somehow on call July 1st a second straight year. I still have much to learn but just wanted to share some knowledge nuggets for any incoming residents (and perhaps save my fellow urologists a consult or two) Introducing Foley’s folly: A foolproof guide to catheterization. 🧵1/13

Somehow on call July 1st a second straight year. I still have much to learn but just wanted to share some knowledge nuggets for any incoming residents (and perhaps save my fellow urologists a consult or two)

Introducing Foley’s folly: A foolproof guide to catheterization. 🧵1/13
Tom Powles (@tompowles1) 's Twitter Profile Photo

Enfortumab vedotin & Pembrolizumab improving PFS & OS by 55% & 53% respectively compared to platinum based chemo in 1st line UC (+avelumab in 30%). Chemo has not been beaten before (despite multiple efforts). RR and CR of 68% & 29% is hard to beat. DOR not reached (1/3)#ESMO2023

Enfortumab vedotin &amp; Pembrolizumab improving PFS &amp; OS by 55% &amp; 53% respectively compared to platinum based chemo in 1st line UC (+avelumab in 30%).  Chemo has not been beaten before (despite multiple efforts). RR and CR of 68% &amp; 29% is hard to beat. DOR not reached (1/3)#ESMO2023
David Zekan, MD (@zekan_david) 's Twitter Profile Photo

Very excited to be one of the #urologists in the minority at #GU24. Lots to glean from our med onc and rad onc colleagues. Check out #L11 tomorrow evening for an update on #dicycloplatin in #urothelialcarcinoma and DM me if you want to meet up! #oralplatinum #GUASCO

David Zekan, MD (@zekan_david) 's Twitter Profile Photo

Beyond excited to match with Fox Chase - Temple Urologic Institute: FCCC Branch for YUO fellowship! Congrats to all applicants on some incredible matches today!! I couldn’t have done any of it without my mentors Adam Luchey Stanley Zaslau @twitterlessHajiran @twitterlessSalkini WVU Urology